Hermine, O., Mariette, X., Porcher, R., Djossou, F., Nguyen, Y., Arlet, J., Savale, L., Diehl, J. L., Georgin-Lavialle, S., Cadranel, J., Pialoux, G., Lacombe, K., Mekinian, A., Gros, H., Lescure, X., Ghosn, J., Coupez, E., Grapin, K., Rapp, C., Michel, M., Lecapitaine, A. L., Michot, J. M., Costedoat-Chalumeau, N., Nguyen, L. B. L., Semerano, L., Raffi, F., Aguillar, C., Rouzaud, C., Gottenberg, J. E., Hansmann, Y., Bienvenu, B., London, J., Fantchou, F. S., Ackermann, F., Gros, A., Morel, A., Gambier, N., Sène, D., Mégarbane, B., Azoulay, E., Bureau, S., Dougados, M., Emmerich, J., Fartoukh, M., Guidet, B., Humbert, M., Mahevas, M., Pène, F., Schlemmer, F., Pourcher-Martinez, V., Tibi, A., Baron, G., Perrodeau, E., Baron, S., Steg, G., Yazdapanah, Y., Simon, T., Resche-Rigon, M., Tharaux, P., Ravaud, P., & , (2022). tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group. EClinicalMedicine, 46, . http://access.bl.uk/ark:/81055/vdc_100153807646.0x000001